Ardelyx Inc Sustainability Reports
Ardelyx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative, first-in-class medicines. The company develops and markets small molecule therapeutics targeted at gastrointestinal and cardiorenal diseases, including IBSRELA and XPHOZAH.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300F542QR4SXHCY32
FIGI: BBG001WH4F33
6 reports from 2018 to 2024
